NCT00910520 Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence Status COMPLETED Phase PHASE3
NCT00903045 Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder Status COMPLETED Phase PHASE4
NCT00902421 Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients Status COMPLETED Phase PHASE4
NCT00901251 Reproducibility Study of Over Active Bladder Symptom Score [OABSS] Status COMPLETED Phase N/A
NCT00892450 Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease Status COMPLETED Phase NA
NCT00884104 A Study to Evaluate Add on Effect of Solifenacin in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 Weeks Status COMPLETED Phase PHASE4
NCT00876447 A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00863551 Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial Status COMPLETED Phase PHASE4
NCT00862745 Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES) Status COMPLETED Phase PHASE4
NCT00857896 Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years Status COMPLETED Phase PHASE2
NCT00856570 A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00836381 Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder Status COMPLETED Phase PHASE4
NCT00821184 Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder Status TERMINATED Phase PHASE3
NCT00795925 Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder Status COMPLETED Phase PHASE2